Kotra Industries Bhd dividend calculator – KOTRA INDUSTRIES BHD Declares 0.1 Cash Dividend

March 18, 2023

Dividends Yield

On March 1 2023, KOTRA INDUSTRIES BHD ($KLSE:0002) announced the declaration of a 0.1 cash dividend for its shareholders. This follows the annual dividend per share of 0.16 MYR, 0.16 MYR, and 0.06 MYR for the past three years, resulting in dividend yields of 4.9%, 4.9%, and 2.22%, with an average dividend yield of 4.01%. For those who are looking for dividend stocks to invest in, KOTRA INDUSTRIES BHD could be a possible option to consider.

The ex-dividend date is set to be on March 13 2023, and any shareholders of record on that date are eligible to receive the said dividend. This provides investors the opportunity to reap returns through regular dividends, while also taking part in the growth of KOTRA INDUSTRIES BHD.

Stock Price

The stock opened at RM6.1 and closed at the same price, down by 0.5% from its last closing price of 6.1. In light of the dividend announcement, the company has seen an overall decline in its stock price. This dividend announcement has been welcomed by shareholders as it is a positive sign of the company’s financial strength and stability.

This move will further benefit shareholders as they will be able to increase their holding in the company. KOTRA INDUSTRIES BHD has consistently declared dividends to shareholders over the years, and this dividend declaration is yet another testament to the company’s strong financial performance. The board of directors of KOTRA INDUSTRIES BHD has taken a proactive approach in rewarding its shareholders, and this dividend declaration is yet another positive step in that direction. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Kotra Industries Bhd. More…

    Total Revenues Net Income Net Margin
    231.01 67.92 29.1%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Kotra Industries Bhd. More…

    Operations Investing Financing
    91.17 -54.03 -48
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Kotra Industries Bhd. More…

    Total Assets Total Liabilities Book Value Per Share
    313.17 58.04 1.72
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Kotra Industries Bhd are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    11.0% 34.7% 28.0%
    FCF Margin ROE ROA
    27.5% 15.6% 12.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    GoodWhale recently conducted an analysis of the wellbeing of KOTRA INDUSTRIES BHD and the results can be clearly seen in our star chart. The analysis indicates that KOTRA INDUSTRIES BHD is strong in terms of asset, dividend, growth, and profitability. We gave KOTRA INDUSTRIES BHD a health score of 10/10 with regard to its cashflows and debt. This is evidence that it is capable of riding out any crisis without the risk of bankruptcy. From our analysis, we classified KOTRA INDUSTRIES BHD as a ‘gorilla’, a type of company that has achieved stable and high revenue or earnings growth due to its strong competitive advantage. This would make KOTRA INDUSTRIES BHD an attractive target to investors looking for stability and consistent growth. Therefore, it is likely that long-term, value, and active traders would be interested in this particular investment. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    Kotra Industries Bhd is in a highly competitive market, facing stiff competition from the likes of Extrawell Pharmaceutical Holdings Ltd, Y.S.P. Southeast Asia Holding Bhd and Apeloa Pharmaceutical Co Ltd. All four companies are working hard to gain the upper hand in the market and make their mark as industry leaders. With each company offering unique products and services, it promises to be a battle of wits and resources in order to gain the ultimate prize of market share.

    – Extrawell Pharmaceutical Holdings Ltd ($SEHK:00858)

    ExtraWell Pharmaceutical Holdings Ltd is a pharmaceutical manufacturer that develops, produces, and markets prescription, over-the-counter, and generic drugs. The company’s market cap is currently at 162.52 million as of 2023, which is indicative of its solid financial performance. The company also has a Return on Equity of 5.4%, which indicates that the company is producing a good return on the shareholders’ investments. The company has an extensive portfolio of products, and its products are sold in multiple markets around the world, providing it with a unique competitive advantage.

    – Y.S.P. Southeast Asia Holding Bhd ($KLSE:7178)

    Y.S.P. Southeast Asia Holding Bhd is a Malaysian-based company that specializes in the production of consumer products, food and beverage, and pharmaceuticals. The company has a market capitalization of 327.51M as of 2023, which indicates its current size and presence in the market. This market capitalization has grown steadily in recent years, with strong revenue and profit growth. In addition, Y.S.P. Southeast Asia Holding Bhd has achieved a Return on Equity (ROE) of 8.4%, which is a measure of how effectively the company has used its equity to generate profits and provides an indication of the profitability of its investments. This is a sign of the company’s strong financial performance and solid financial position.

    – Apeloa Pharmaceutical Co Ltd ($SZSE:000739)

    Apeloa Pharmaceutical Co Ltd is a leading pharmaceutical company based in China that specializes in developing and manufacturing innovative drugs that are used to treat a range of diseases. The company’s market capitalization as of 2023 is 25.44 billion dollars, with a Return on Equity of 12.52%. This suggests that Apeloa has generated a good amount of profits on its equity investments, providing the company with a healthy and profitable financial outlook. Apeloa’s investments in research and development have yielded lucrative dividends and their commitment to providing quality drugs has helped them become a leader in the industry.


    Investing in KOTRA INDUSTRIES BHD can be a worthwhile option, as the company has offered dividends of 0.16 MYR per share over the past three years, resulting in an average dividend yield of 4.01%. This is significantly higher than the average yield of the general market, making KOTRA INDUSTRIES BHD an attractive proposition for investors looking to maximize their returns. As such, an investment in KOTRA INDUSTRIES BHD could be a good choice for investors seeking reliable income from their investments.

    Recent Posts

    Leave a Comment